Israel Robert J

Avg. Two Year Performance

No purchase track record

24% Avg. Sale Return

11% Compound

	1 Mo	3 Mo	6 Mo	1 Yr	2 Yr
Average Purchase Return	--	--	--	--	--
Purchase Success Rate	--	--	--	--	--
Average Sale Return	1%	6%	10%	7%	24%
Sale Success Rate	28 of 52	31 of 52	33 of 52	35 of 52	38 of 52

Progenics Pharmaceuticals I...

Drugs » Biotechnology

Executive Vice President, Medi:

Holdings: 35.05K shares

Sentiment

Avg. Two Year Performance

No purchase track record

No sale track record

Last Three Months:

0 Net Amount

Buy:	0	--
Sell:	0	--